Literature DB >> 21316336

Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain.

Francisco Ciruela1, Maricel Gómez-Soler, Diego Guidolin, Dasiel O Borroto-Escuela, Luigi F Agnati, Kjell Fuxe, Víctor Fernández-Dueñas.   

Abstract

While the G protein-coupled receptor (GPCR) oligomerization has been questioned during the last fifteen years, the existence of a multi-receptor complex involving direct receptor-receptor interactions, called receptor oligomers, begins to be widely accepted. Eventually, it has been postulated that oligomers constitute a distinct functional form of the GPCRs with essential receptorial features. Also, it has been proven, under certain circumstances, that the GPCR oligomerization phenomenon is crucial for the receptor biosynthesis, maturation, trafficking, plasma membrane diffusion, and pharmacology and signalling. Adenosine receptors are GPCRs that mediate the physiological functions of adenosine and indeed these receptors do also oligomerize. Accordingly, adenosine receptor oligomers may improve the molecular mechanism by which extracellular adenosine signals are transferred to the G proteins in the process of receptor transduction. Importantly, these adenosine receptor-containing oligomers may allow not only the control of the adenosinergic function but also the fine-tuning modulation of other neurotransmitter systems (i.e. dopaminergic and glutamatergic transmission). Overall, we underscore here recent significant developments based on adenosine receptor oligomerization that are essential for acquiring a better understanding of neurotransmission in the central nervous system under normal and pathological conditions.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316336     DOI: 10.1016/j.bbamem.2011.02.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Adenosine effects on inhibitory synaptic transmission and excitation-inhibition balance in the rat neocortex.

Authors:  Pei Zhang; Nicholas M Bannon; Vladimir Ilin; Maxim Volgushev; Marina Chistiakova
Journal:  J Physiol       Date:  2015-01-07       Impact factor: 5.182

3.  A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson's disease.

Authors:  Akane Hayashi; Naoya Matsunaga; Hiroyuki Okazaki; Keisuke Kakimoto; Yoshinori Kimura; Hiroki Azuma; Eriko Ikeda; Takeshi Shiba; Mayumi Yamato; Ken-Ichi Yamada; Satoru Koyanagi; Shigehiro Ohdo
Journal:  Neuromolecular Med       Date:  2013-01-05       Impact factor: 3.843

4.  Adenosine A2a receptors form distinct oligomers in protein detergent complexes.

Authors:  Nicole S Schonenbach; Monica D Rieth; Songi Han; Michelle A O'Malley
Journal:  FEBS Lett       Date:  2016-09-02       Impact factor: 4.124

5.  Modulation of synaptic transmission by adenosine in layer 2/3 of the rat visual cortex in vitro.

Authors:  N M Bannon; P Zhang; V Ilin; M Chistiakova; M Volgushev
Journal:  Neuroscience       Date:  2013-12-16       Impact factor: 3.590

6.  Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.

Authors:  Verònica Casadó-Anguera; Estefanía Moreno; Josefa Mallol; Sergi Ferré; Enric I Canela; Antoni Cortés; Vicent Casadó
Journal:  Pharmacol Res       Date:  2018-11-22       Impact factor: 7.658

7.  Indirect Medium Spiny Neurons in the Dorsomedial Striatum Regulate Ethanol-Containing Conditioned Reward Seeking.

Authors:  Sa-Ik Hong; Seungwoo Kang; Jiang-Fan Chen; Doo-Sup Choi
Journal:  J Neurosci       Date:  2019-07-17       Impact factor: 6.167

8.  Receptor antagonism/agonism can be uncoupled from pharmacoperone activity.

Authors:  Jo Ann Janovick; Timothy P Spicer; Emery Smith; Thomas D Bannister; Terry Kenakin; Louis Scampavia; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2016-07-04       Impact factor: 4.102

9.  Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.

Authors:  Richard L Bell; Kelle M Franklin; Sheketha R Hauser; Feng C Zhou
Journal:  Recent Pat CNS Drug Discov       Date:  2012-08

10.  Acute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained men.

Authors:  Benjamin Wax; Andreas N Kavazis; Heather E Webb; Stanley P Brown
Journal:  J Int Soc Sports Nutr       Date:  2012-04-17       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.